Managing hypertension in obstructive sleep apnea: The interplay of continuous positive airway pressure, medication and chronotherapy

Journal of Hypertension

Volumn 28, Issue 5, 2010, Pages 875-882

  Tsioufis, Costas ^a   Kasiakogias, Alexandros ^a   Thomopoulos, Costas ^a   Manolis, Athanasios ^b   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Asklepeion Hospital   (Greece)

Author keywords

Chronotherapy; Circadian rhythm; Continuous positive airway pressure; Hypertension; Sleep apnea

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILAZAPRIL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; ISRADIPINE; LOSARTAN; METOPROLOL; SPIRAPRIL; THIAZIDE DIURETIC AGENT; VALSARTAN;

ANTIHYPERTENSIVE THERAPY; CHRONOTHERAPY; CLINICAL TRIAL; DAYTIME SOMNOLENCE; DISEASE SEVERITY; DRUG MECHANISM; HEART HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOXEMIA; LIFESTYLE MODIFICATION; PATIENT ATTITUDE; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; UNSPECIFIED SIDE EFFECT;

EID: 77951266289     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328336ed85     Document Type: Review

References (99)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230-1235. (Pubitemid 23115702)
2. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342:1378-1384. (Pubitemid 30262394)
3. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320:479-482. (Pubitemid 30173118)
4. McNicholas WT, Bonsigore MR, Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29:156-178.
5. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008; 118:1080-1111.
6. McNicholas WT. Diagnosis of obstructive sleep apnea in adults. Proc Am Thorac Soc 2008; 5:154-160. (Pubitemid 351237873)
7. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993; 103:30-36. (Pubitemid 23027228)
8. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131:485-491. (Pubitemid 29482391)
9. Gus M, Gonçalves SC, Martinez D, de Abreu Silva EO, Moreira LB, Fuchs SC, Fuchs FD. Risk for obstructive sleep apnea by Berlin Questionnaire, but not daytime sleepiness, is associated with resistant hypertension: a case-control study. Am J Hypertens 2008; 21:832-835. (Pubitemid 351913620)
10. Flemons WW, Whitelaw WA, Brant R, Remmers JE. Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med 1994; 150:1279-1285. (Pubitemid 24356641)
11. Netzer N, Eliasson AH, Netzer C, Kristo DA. Overnight pulse oximetry for sleep-disordered breathing in adults: a review. Chest 2001; 120:625-633. (Pubitemid 32881286)
12. Mulgrew AT, FoxN, Ayas NT, Ryan CF. Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study. Ann Intern Med 2007; 146:157-166.
13. Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005; 28:499-521.
14. Baguet JP, Hammer L, Lévy P, Pierre H, Rossini E, Mouret S, et al. Nighttime and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 2005; 23:521-527. (Pubitemid 40684709)
15. Sharabi Y, Scope A, Chorney N, Grotto I, Dagan Y. Diastolic blood pressure is the first to rise in association with early subclinical obstructive sleep apnea: lessons from periodic examination screening. Am J Hypertens 2003; 16:236-239. (Pubitemid 36293070)
16. Baguet JP, Lévy P, Barone-Rochette G, Tamisier R, Pierre H, Peeters M, et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens 2008; 26:885-892. (Pubitemid 351520975)
17. Lavie P, Hofftein V. Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep 2001; 24:721-725. (Pubitemid 32823738)
18. Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 2000; 18:679-685. (Pubitemid 30406738)
19. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, et al. High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens 2001; 19:2271-2277. (Pubitemid 33135251)
20. Portaluppi F, Provini F, Cortelli P, Plazzi G, Bertozzi N, Manfredini R, et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 1997; 15:1227-1233. (Pubitemid 27453174)
21. Pankow W, Nabe B, Lies A, Becker H, Köhler U, Kohl FV, Lohmann FW. Influence of sleep apnea on24-h blood pressure. Chest 1997; 112:1253-1258. (Pubitemid 27497856)
22. Hla KM, Young T, Finn L, Peppard PE, Szklo-Coxe M, Stubbs M. Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 2008; 31:795-800. (Pubitemid 351810508)
23. Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE. Syndrome Z: the interaction of sleep apnea vascular risk factors and heart disease. Thorax 1998; 53S:25-28. (Pubitemid 28467811)
24. Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005; 99:1998-2007. (Pubitemid 41547203)
25. Roche F, Sforza E, Pichot V, Maudoux D, Garcin A, Celle S, et al. Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 2009; 10:882-886.
26. Thomopoulos C, Tsioufis C, Dimitriadis K, Tsiachris D, Tousoulis D, Manolis A, et al. Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives. J Hum Hypertens 2009; 23:65-67.
27. Tsioufis C, Thomopoulos K, Dimitriadis K, Amfilochiou A, Tousoulis D, Alchanatis M, et al. The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects. J Hypertens 2007; 25:141-146. (Pubitemid 44885675)
28. Tsioufis C, Thomopoulos C, Dimitriadis K, Amfilochiou A, Tsiachris D, SelimaM, et al. Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. Am J Kidney Dis 2008; 52:285-293. (Pubitemid 351978143)
29. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25:1751-1762. (Pubitemid 46924065)
30. Marrone O, Romano S, Insalaco G, Bonsignore MR, Salvaggio A, Bonsignore G. Influence of sampling interval on the evaluation of nocturnal blood pressure in subjects with and without obstructive sleep apnoea. Eur Respir J 2000; 16:653-658.
31. Davies RJ, Jenkins NE, Stradling JR. Effect of measuring ambulatory blood pressure on sleep and on blood pressure during sleep. BMJ 1994; 308:820-823. (Pubitemid 24101188)
32. Voogel AJ, van Montfrans GA. Reproducibility of twenty-four-hour finger arterial blood pressure, variability and systemic hemodynamics. J Hypertens 1997; 15:1761-1765.
33. Omboni S, Parati G, Castiglioni P, Di Rienzo M, Imholz BP, Langewouters GJ, et al. Estimation of blood pressure variability from 24-h ambulatory finger blood pressure. Hypertension 1998; 32:52-58. (Pubitemid 28324124)
34. Shirasaki O, Yamashita S, Kawara S, Tagami K, Ishikawa J, Shimada K, Kario K. A new technique for detecting sleep apnea-related 'midnight' surge of blood pressure. Hypertens Res 2006; 29:695-702. (Pubitemid 44605368)
35. Franco V, Oparil S, Carretero OA. Hypertensive therapy: part II. Circulation 2004; 109:3081-3088.
36. Ryan CF. Sleep x 9: an approach to treatment of obstructive sleep apnoea/hypopnoea syndrome including upper airway surgery. Thorax 2005; 60:595-604.
37. Quan SF, O'Connor GT, Quan JS, Redline S, Resnick HE, Shahar E, et al. Association of physical activity with sleep-disordered breathing. Sleep Breath 2007; 11:149-157. (Pubitemid 47307843)
38. Fritscher LG, Canani S, Mottin CC, Fritscher CC, Berleze D, Chapman K, Chatkin JM. Bariatric surgery in the treatment of obstructive sleep apnea in morbidly obese patients. Respiration 2007; 74:647-652. (Pubitemid 350164510)
39. Vitiello MV, Prinz PN, Halter JB. Sodium-restricted diet increases nighttime plasma norepinephrine and impairs sleep patterns in man. J Clin Endocrinol Metab 1983; 56:553-556.
40. Sullivan CE, Issa FG, Berthon-Jones M, Eves L Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1981; 1:862-865. (Pubitemid 11099316)
41. Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005; 127:2076-2084. (Pubitemid 46260099)
42. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365:1046-1053. (Pubitemid 40386782)
43. Loube DI, Gay PC, Strohl KP, Pack AI, White DP, Collop NA. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest 1999; 115:863-866. (Pubitemid 29129973)
44. KushidaCA, Littner MR, Hirshkowitz M, MorgenthalerTI, Alessi CA, Bailey D, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006; 29:375-380. (Pubitemid 44019961)
45. Ali NJ, Davies RJ, Fleetham JA, Stradling JR. The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea. Chest 1992; 101:1526-1532.
46. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96:1897-1904.
47. Akashiba T, Minemura H, Yamamoto H, Kosaka N, Saito O, Horie T. Nasal continuous positive airway pressure changes blood pressure 'nondippers' to 'dippers' in patients with obstructive sleep apnea. Sleep 1999; 22:849-853. (Pubitemid 29526505)
48. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in 'nondippers'. Sleep 1996; 19:378-381. (Pubitemid 26256751)
49. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000; 35:144-147. (Pubitemid 30054251)
50. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163:344-348. (Pubitemid 32158510)
51. Barbé F, Mayoralas LR, Duran J, Masa JF, Maimó A, Montserrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trial. Ann Intern Med 2001; 134:1015-1023. (Pubitemid 32488655)
52. Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359:204-210. (Pubitemid 34113817)
53. Barnes M, Houston D, Worsnop CJ, Neill AM, Mykytyn IJ, Kay A, et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165:773-780. (Pubitemid 34229646)
54. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, Peter JH. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107:68-73. (Pubitemid 36070935)
55. Norman D, Loredo JS, Nelesen RA, Ancoli-Israel S, Mills PJ, Ziegler MG, Dimsdale JE. Effects of continuous positive airway pressure versus supplemental oxygen on 24-h ambulatory blood pressure. Hypertension 2006; 47:840-845. (Pubitemid 44297553)
56. Robinson GV, Smith DM, Langford SA, Davies RJO, Stradling JR. Continuous positive airway pressure does not reduce blood pressure in non sleepy hypertensive OSA patients. Eur Respir J 2006; 27:1229-1235.
57. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, Merino-Sanchez M, Gonzalez-Benitez MA, Beltran-Robles M, Almeida-Gonzalez C. Effects of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006; 129:1459-1467. (Pubitemid 43894973)
58. Hui DS, To KW, Ko FW, Fok JP, Chan MC, Ngai JC, et al. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax 2006; 61:1083-1090.
59. Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007; 29:720-727. (Pubitemid 46554622)
60. Kohler M, Pepperell JC, Casadei B, Craig S, Crosthwaite N, Stradling JR, Davies RJ. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 2008; 32:1488-1496.
61. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007; 50:417-423. (Pubitemid 47205794)
62. Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, Velkeniers B. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007; 167:757-764. (Pubitemid 46658332)
63. Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E, et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007; 185:67-72. (Pubitemid 46571874)
64. Lombardi C, Parati G, Cortelli P, Provini F, Vetrugno R, Plazzi G, et al. Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. J Sleep Res 2008; 17:263-270.
65. Kapur VK, Resnick HE, Gottlieb DJ, Sleep Heart Health Study Group. Sleep disordered breathing and hypertension: does self-reported sleepiness modify the association? Sleep 2008; 31:1127-1132.
66. Robinson GV, Langford BA, Smith DM, Stradling JR. Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA). Thorax 2008; 63:855-859.
67. Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, Bradley TD. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21:241-247. (Pubitemid 36204537)
68. Mart́nez-Garća MA, Gómez-Aldarav́ R, Soler-Cataluña JJ, Mart́nez TG, Berná cer-Alpera B, Román-Sá nchez P. Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Respir J 2007; 29:951-957. (Pubitemid 46711900)
69. Bö rgel J, Sanner BM, Keskin F, Bittlinsky A, Bartels NK, Bü chner N, et al. Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs. Am J Hypertens 2004; 17:1081-1087. (Pubitemid 40029403)
70. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165:1217-1239. (Pubitemid 34461732)
71. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008; 5:173-178.
72. Yetkin O, Kunter E, Gunen H. CPAP compliance in patients with obstructive sleep apnea syndrome. Sleep Breath 2008; 12:365-367.
73. Ruttanaumpawan P, Nopmaneejumruslers C, Logan AG, Lazarescu A, Qian I, Bradley TD. Association between refractory hypertension and obstructive sleep apnea. J Hypertens 2009; 27:1439-1445.
74. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161:1423-1428. (Pubitemid 30329007)
75. Møller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-h blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16:274-280. (Pubitemid 36384754)
76. Kageyama N, Nomura M, Nakaya Y, Watanabe T, Ito S. Relationship between adhesion molecules with hs-CRP and changes therein after ARB (Valsartan) administration in patients with obstructive sleep apnea syndrome. J Med Invest 2006; 53:134-139.
77. Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 2004; 43:518-524. (Pubitemid 38282420)
78. Pimenta E, Calhoun DA, Oparil S. Sleep apnea, aldosterone, and resistant hypertension. Prog Cardiovasc Dis 2009; 51:371-380.
79. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117:510-526.
80. Bucca CB, Brussino L, Battisti A, Mutani R, Rolla G, Mangiardi L, Cicolin A. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 2007; 132:440-446. (Pubitemid 47282374)
81. Pelttari LH, Hietanen EK, Salo TT, Kataja MJ, Kantola IM. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Am J Hypertens 1998; 11:272-279.
82. Salo TM, Kantola I, Voipio-Pulkki LM, Pelttari L, Viikari JS. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients-assessment by spectral analysis of heart rate and blood pressure variability. Eur J Clin Pharmacol 1999; 55:191-198. (Pubitemid 29244646)
83. Mayer J, Weichler U, Herres-Mayer B, Schneider H, Marx U, Peter JH. Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity. J Cardiovasc Pharmacol 1990; 16:952-961.
84. Somers VK, Dyken ME, Mark AL, Abboud FM. Parasympathetic hyperresponsiveness and bradyarrhythmias during apnoea in hypertension. Clin Auton Res 1992; 2:171-176.
85. Kantola I, Rauhala E, Erkinjuntti M, Mansury L. Sleep disturbances in hypertension: a double-blind study between isradipine and metoprolol. J Cardiovasc Pharmacol 1991; 18 (Suppl 3):S41-S45.
86. Boudoulas H, Schmidt H, Gelens P, Clark RW, Lewis RP. Case reports on deterioration of sleep apnea during therapy with propranolol: preliminary studies. Res Commun Chem Patol Pharmacol 1983; 39:3-10. (Pubitemid 13184846)
87. Weichler U, Herres-Mayer B, Mayer J, Weber K, Hoffmann R, Peter JH. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology 1991; 78:124-130.
88. Cicolin A, Mangiardi L, Mutani R, Bucca C. Angiotensin-converting enzyme inhibitors and obstructive sleep apnea. Mayo Clin Proc 2006; 81:53-55. (Pubitemid 43054318)
89. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Cofield SS, Harding SM, Calhoun DA. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007; 131:453-459. (Pubitemid 46298490)
90. Issa FG. Effect of clonidine in obstructive sleep apnea. Am Rev Respir Dis 1992; 145:435-439.
91. Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98:1071-1077. (Pubitemid 28420698)
92. Nagata K, Osada N, Shimazaki M, Kida K, Yoneyama K, Tsuchiya A, et al. Diurnal blood pressure variation in patients with sleep apnea syndrome. Hypertens Res 2008; 31:185-191. (Pubitemid 351461096)
93. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45:240-245. (Pubitemid 40179967)
94. Hermida RC, Ayala DE, Calvo C. Optimal timing for antihypertensive dosing: focus on valsartan. Ther Clin Risk Manag 2007; 3:119-131. (Pubitemid 46671828)
95. Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am J Kidney Dis 2007; 50:901-903. (Pubitemid 350122805)
96. Umeda T, Naomi S, Iwaoka T, Inoue J, Sasaki M, Ideguchi Y, Sato T. Timing for administration of an antihypertensive drug in the treatment of essential hypertension. Hypertension 1994; 23 (1 Suppl): 1211-1214. (Pubitemid 24020452)
97. Hermida RC, Ayala DE, Mojón A, Fernández JR. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hypertens 2008; 21:948-954.
98. Hermida RC, Ayala DE, Fernández JR, Calvo C. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 2008; 51:69-76. (Pubitemid 350307106)
99. Smolensky MH, Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens 2001; 14:280S-290S. (Pubitemid 32868544)